Cargando…

Molecular Mechanisms of Drug Resistance in Glioblastoma

Glioblastoma multiforme (GBM) is the most common and fatal primary brain tumor, is highly resistant to conventional radiation and chemotherapy, and is not amenable to effective surgical resection. The present review summarizes recent advances in our understanding of the molecular mechanisms of thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dymova, Maya A., Kuligina, Elena V., Richter, Vladimir A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232134/ https://www.ncbi.nlm.nih.gov/pubmed/34203727 http://dx.doi.org/10.3390/ijms22126385

Ejemplares similares

Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy
por: Dymova, Maya A., et al.
Publicado: (2022)

Post-Transcriptional Modifications of RNA as Regulators of Apoptosis in Glioblastoma
por: Dome, Anton, et al.
Publicado: (2022)

Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells
por: Dmitrieva, Maria D., et al.
Publicado: (2020)

Boron neutron capture therapy: Current status and future perspectives
por: Dymova, Mayya Alexandrovna, et al.
Publicado: (2020)

MicroRNA and mRNA Expression Changes in Glioblastoma Cells Cultivated under Conditions of Neurosphere Formation
por: Dymova, Maya A., et al.
Publicado: (2022)

Modification of a Tumor-Targeting Bacteriophage for Potential Diagnostic Applications
por: Dymova, Maya Alexandrovna, et al.
Publicado: (2021)

Bacteriophage-Mediated Cancer Gene Therapy
por: Petrov, Gleb, et al.
Publicado: (2022)

Double Recombinant Vaccinia Virus: A Candidate Drug against Human Glioblastoma
por: Vasileva, Natalia, et al.
Publicado: (2021)

Tumor Cell-Specific 2′-Fluoro RNA Aptamer Conjugated with Closo-Dodecaborate as A Potential Agent for Boron Neutron Capture Therapy
por: Vorobyeva, Mariya A., et al.
Publicado: (2021)

Aptamers for Addressed Boron Delivery in BNCT: Effect of Boron Cluster Attachment Site on Functional Activity
por: Novopashina, Darya S., et al.
Publicado: (2022)

The Signaling Pathways Controlling the Efficacy of Glioblastoma Therapy
por: Vasileva, N. S., et al.
Publicado: (2022)

Transcriptome Changes in Glioma Cells Cultivated under Conditions of Neurosphere Formation
por: Vasileva, Natalia S., et al.
Publicado: (2022)

Molecular Mechanisms of Treatment Resistance in Glioblastoma
por: Ou, Alexander, et al.
Publicado: (2020)

Transcriptome Changes in Glioma Cells upon Infection with the Oncolytic Virus VV-GMCSF-Lact
por: Semenov, Dmitriy V., et al.
Publicado: (2023)

Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia
por: Dymova, Maya A, et al.
Publicado: (2014)

Molecular Mechanisms of the Cytotoxic Effect of Recombinant Selenoprotein SELENOM on Human Glioblastoma Cells
por: Rogachev, Vladimir V., et al.
Publicado: (2023)

Regulatory Role of Small Nucleolar RNAs in Human Diseases
por: Stepanov, Grigory A., et al.
Publicado: (2015)

Mechanisms of EGFR Resistance in Glioblastoma
por: Pan, Peter C., et al.
Publicado: (2020)

Molecular testing for colorectal cancer: Clinical applications
por: Imyanitov, Evgeny, et al.
Publicado: (2021)

Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
por: Yalamarty, Satya Siva Kishan, et al.
Publicado: (2023)

Glioblastoma Multiforme Therapy and Mechanisms of Resistance
por: Ramirez, Yulian P., et al.
Publicado: (2013)

Hippo Pathway in Regulating Drug Resistance of Glioblastoma
por: Casati, Giacomo, et al.
Publicado: (2021)

Drug resistance in glioblastoma: are persisters the key to therapy?
por: Oliver, Lisa, et al.
Publicado: (2020)

Molecular mechanisms in multiple myeloma drug resistance
por: Nikesitch, Nicholas, et al.
Publicado: (2016)

Molecular Mechanisms of Drug Resistance in Staphylococcus aureus
por: Mlynarczyk-Bonikowska, Beata, et al.
Publicado: (2022)

Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms
por: Salami, Raziyeh, et al.
Publicado: (2022)

Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance
por: Nguyen, Ha S., et al.
Publicado: (2018)

Molecular Mechanisms of KDELC2 on Glioblastoma Tumorigenesis and Temozolomide Resistance
por: Tsai, Yu-Ling, et al.
Publicado: (2020)

Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
por: Singh, Neha, et al.
Publicado: (2021)

Deciphering the Role of Autophagy in Treatment of Resistance Mechanisms in Glioblastoma
por: Khan, Imran, et al.
Publicado: (2021)

Resistance Mechanisms and Barriers to Successful Immunotherapy for Treating Glioblastoma
por: Adhikaree, Jason, et al.
Publicado: (2020)

Purification and Characterization of Apoptotic Factors from Human Milk
por: Semenov, Dmitry V., et al.
Publicado: (2001)

Roles of Chromatin Remodelling and Molecular Heterogeneity in Therapy Resistance in Glioblastoma
por: Chen, Huey-Miin, et al.
Publicado: (2022)

Molecular and Cellular Mechanisms of Glioblastoma
por: Castresana, Javier S., et al.
Publicado: (2021)

Molecular & genetic characteristics of Mycobacterium tuberculosis strains circulating in the southern part of West Siberia
por: Pasechnik, Oksana, et al.
Publicado: (2017)

Phage Peptide Libraries As a Source of Targeted Ligands
por: Nemudraya, A. A., et al.
Publicado: (2016)

Molecular Mechanisms of Drug Resistance and Epidemiology of Multidrug-Resistant Variants of Neisseria gonorrhoeae
por: Mlynarczyk-Bonikowska, Beata, et al.
Publicado: (2022)

Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma
por: Marin, Jose J. G., et al.
Publicado: (2020)

Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials
por: Bruinsmann, Franciele Aline, et al.
Publicado: (2019)

Molecular Mechanism of Drug Resistance
por: Ray, Shilpa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6t12grp6o427mpeub42h45184g